» Articles » PMID: 22202674

Glutathione-dependent Reductive Stress Triggers Mitochondrial Oxidation and Cytotoxicity

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2011 Dec 29
PMID 22202674
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the effects of the predominant nonprotein thiol, glutathione (GSH), on redox homeostasis, we employed complementary pharmacological and genetic strategies to determine the consequences of both loss- and gain-of-function GSH content in vitro. We monitored the redox events in the cytosol and mitochondria using reduction-oxidation sensitive green fluorescent protein (roGFP) probes and the level of reduced/oxidized thioredoxins (Trxs). Either H(2)O(2) or the Trx reductase inhibitor 1-chloro-2,4-dinitrobenzene (DNCB), in embryonic rat heart (H9c2) cells, evoked 8 or 50 mV more oxidizing glutathione redox potential, E(hc) (GSSG/2GSH), respectively. In contrast, N-acetyl-L-cysteine (NAC) treatment in H9c2 cells, or overexpression of either the glutamate cysteine ligase (GCL) catalytic subunit (GCLC) or GCL modifier subunit (GCLM) in human embryonic kidney 293 T (HEK293T) cells, led to 3- to 4-fold increase of GSH and caused 7 or 12 mV more reducing E(hc), respectively. This condition paradoxically increased the level of mitochondrial oxidation, as demonstrated by redox shifts in mitochondrial roGFP and Trx2. Lastly, either NAC treatment (EC(50) 4 mM) or either GCLC or GCLM overexpression exhibited increased cytotoxicity and the susceptibility to the more reducing milieu was achieved at decreased levels of ROS. Taken together, our findings reveal a novel mechanism by which GSH-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.

Citing Articles

The Role of Reductive Stress in the Pathogenesis of Endocrine-Related Metabolic Diseases and Cancer.

Mladenov M, Sazdova I, Hadzi-Petrushev N, Konakchieva R, Gagov H Int J Mol Sci. 2025; 26(5).

PMID: 40076537 PMC: 11899626. DOI: 10.3390/ijms26051910.


Singlet Oxygen in Photodynamic Therapy.

Cui S, Guo X, Wang S, Wei Z, Huang D, Zhang X Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458915 PMC: 11510636. DOI: 10.3390/ph17101274.


N-acetylcysteine in Kidney Disease: Molecular Mechanisms, Pharmacokinetics, and Clinical Effectiveness.

Hernandez-Cruz E, Aparicio-Trejo O, Hammami F, Bar-Shalom D, Tepel M, Pedraza-Chaverri J Kidney Int Rep. 2024; 9(10):2883-2903.

PMID: 39430194 PMC: 11489428. DOI: 10.1016/j.ekir.2024.07.020.


Reductive stress in mitochondria isolated from the carotid body of type 1 diabetic male Wistar rats.

Tejeda-Chavez H, Montero S, Saavedra-Molina A, Lemus M, Tejeda-Luna J, de Alvarez-Buylla E Physiol Rep. 2024; 12(18):e70016.

PMID: 39294856 PMC: 11410552. DOI: 10.14814/phy2.70016.


Effects of concurrent training and N-acetylcysteine supplementation on cardiac remodeling and oxidative stress in middle-aged spontaneously hypertensive rats.

Junqueira A, Gomes M, Lima A, Pontes T, Rodrigues E, Damatto F BMC Cardiovasc Disord. 2024; 24(1):409.

PMID: 39103770 PMC: 11299285. DOI: 10.1186/s12872-024-04075-8.


References
1.
Merten K, Jiang Y, Feng W, Kang Y . Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. J Pharmacol Exp Ther. 2006; 319(2):934-40. DOI: 10.1124/jpet.106.108845. View

2.
Linke K, Jakob U . Not every disulfide lasts forever: disulfide bond formation as a redox switch. Antioxid Redox Signal. 2003; 5(4):425-34. DOI: 10.1089/152308603768295168. View

3.
Gutscher M, Pauleau A, Marty L, Brach T, Wabnitz G, Samstag Y . Real-time imaging of the intracellular glutathione redox potential. Nat Methods. 2008; 5(6):553-9. DOI: 10.1038/nmeth.1212. View

4.
Godwin A, Meister A, ODwyer P, Huang C, Hamilton T, Anderson M . High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A. 1992; 89(7):3070-4. PMC: 48805. DOI: 10.1073/pnas.89.7.3070. View

5.
Rajasekaran N, Connell P, Christians E, Yan L, Taylor R, Orosz A . Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell. 2007; 130(3):427-39. PMC: 2962423. DOI: 10.1016/j.cell.2007.06.044. View